Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02916927Phase 4Completed
Phase 4, randomised, double-blind trial of ketamine in pain (2 arms), sponsored by Alameda Health System. Primary endpoint: Side Effects. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02916927.